Skip to content

Evaluation of the effectiveness of Neuro Psycho Physical Optimization with Conveyer of Modulating Radiance (CMR) in stress-related loss of control and irritability.

A Randomised study to evaluate the effectiveness of Neuro Psycho Physical Optimization (NPPO) with Conveyer of Modulating Radiance (CMR Therapy) in reducing the subjective perception of stress, stress-related loss of control and irritability.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000487415
Acronym
CRMTLCI
Enrollment
700
Registered
2007-09-21
Start date
2001-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Loss of control and irritability are the most frequent signs of general distress. In this study we have used the Psychological Stress Measure (validated in Italian) to test the effectiveness of Neuro Psycho Physical Optimization (NPPO) with Conveyer of Modulating Radiance - CMR Therapy in reducing the subjective perception of stress and stress-related loss of control and irritability. The reduction of the symptomatology of stress and stress-related loss of control and irritability after a NPPO cycle with CMR therapy shows significant results (P<.05) with respect to a control group that was treated with placebo (inactivated CRM).

Interventions

The intervention comprises: A cycle of Neuro Psycho Physical Optimization (NPPO) with Conveyer of Modulating Radiance (CMR therapy). The CMR is a biomedical radiofrequency instrument. The protocol used, called Neuro Psycho Physical Optimization (ONPF), involves the application of a probe of the CMR on specific points of the auricular pavilion for an activation time of roughly 500 mms. The ONPF protocol is activated in a precise sequence on seven auricular points. The protocol envisages 18 sessions of ONPF treatment on alternating days, for eight (8)weeks. Assessment, at baseline and at the end of treatment, with Psychological Stress Measure Test (validated in Italian).

Sponsors

Istituto Rinaldi Fontani
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to -2147483648 No limit
Healthy volunteers
No

Inclusion criteria

Subjects with any type of stress-related symptomatology, over 18 years old.

Exclusion criteria

Subjects with psychiatric symptoms-pathologies, drugs dependence or aged less than 18 years of age were excluded.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026